Shimon Sakaguchi
Shimon Sakaguchi 坂口 志文 | |
|---|---|
Shimon Sakaguchi (坂口 志文, Sakaguchi Shimon, born January 19, 1951) is an
regulatory T cells and to describe their role in the immune system. This discovery is used in the treatment of cancer and autoimmune diseases
.
Biography
Sakaguchi was born in Japan's Shiga Prefecture and educated at Kyoto University.
In 2015, the news agency
signals Shimon Sakaguchi among potential recipients of the Nobel Prize in Physiology or Medicine.[2]
Awards and recognition
- 2004: William B. Coley Award[3]
- 2008: Keio Medical Science Prize[4]
- 2009: Medals of Honor (Japan), purple ribbon[5]
- 2011: Asahi Prize[6]
- 2012: Foreign associate of the National Academy of Sciences[7]
- 2015: Gairdner Foundation International Award.[8]
- 2017: Crafoord Prize
- 2017: Person of Cultural Merit
- 2017: Momofuku Ando Prize[9]
- 2019: Order of Culture
- 2020: Paul Ehrlich and Ludwig Darmstaedter Prize[10]
- 2020: Robert Koch Prize[11]
References
- ^ "Experimental Immunology – Osaka University Immunology Frontier Research Center". IFReC | Osaka University Immunology Frontier Research Center. Retrieved 1 May 2021.
- ^ Announcing the 2015 Citation Laureates by Thomson Reuters.
- ^ William B. Coley Award-Award, Cancer Research Institute (cancerresearch.org)
- Keiō University
- ^ "Distinguished Professor Shimon SAKAGUCHI of IFReC awarded Canada Gairdner International Award". Osaka University. March 26, 2015.
- Asahi Shimbun
- ^ Shimon Sakaguchi National Academy of Sciences
- ^ Shimon Sakaguchi MD, PhD, Gairdner Foundation
- ^ "News & Topics | Osaka University Immunology Frontier Research Center".
- ^ "Goethe-Universität —". www.uni-frankfurt.de.
- ^ "Robert Koch Stiftung – Shimon Sakaguchi". www.robert-koch-stiftung.de.
External links
| International | |
|---|---|
| National | |
| Academics | |
| Other | |
